-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 TKEc06WZwTwYqcgPtyCO2Pg54L7Y14Am4GEUHpLXj98FfFIjR18d25ujTqhjC9KY
 34Zbt17xp7pVU8hiDVAQig==

<SEC-DOCUMENT>0001382218-08-000001.txt : 20080815
<SEC-HEADER>0001382218-08-000001.hdr.sgml : 20080814
<ACCEPTANCE-DATETIME>20080815144441
ACCESSION NUMBER:		0001382218-08-000001
CONFORMED SUBMISSION TYPE:	5
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080630
FILED AS OF DATE:		20080815
DATE AS OF CHANGE:		20080815

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRATED BIOPHARMA INC
		CENTRAL INDEX KEY:			0001016504
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133035216
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205
		BUSINESS PHONE:		9739260816

	MAIL ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRATED HEALTH TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20020912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEM INTERNATIONAL INC
		DATE OF NAME CHANGE:	19960716

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Canarick Robert
		CENTRAL INDEX KEY:			0001382218

	FILING VALUES:
		FORM TYPE:		5
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31668
		FILM NUMBER:		081022572

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		973 926-0816

	MAIL ADDRESS:	
		STREET 1:		C/O INTEGRATED BIOPHARMA, INC.
		STREET 2:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205
</SEC-HEADER>
<DOCUMENT>
<TYPE>5
<SEQUENCE>1
<FILENAME>inb5_robertcanarickex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>5</documentType>

    <periodOfReport>2008-06-30</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <form3HoldingsReported>0</form3HoldingsReported>

    <form4TransactionsReported>1</form4TransactionsReported>

    <issuer>
        <issuerCik>0001016504</issuerCik>
        <issuerName>INTEGRATED BIOPHARMA INC</issuerName>
        <issuerTradingSymbol>INBP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001382218</rptOwnerCik>
            <rptOwnerName>Canarick Robert</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O INTEGRATED BIOPHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>201 ROUTE 22</rptOwnerStreet2>
            <rptOwnerCity>HILLSIDE</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07205</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Unit</value>
            </securityTitle>
            <transactionDate>
                <value>2007-11-16</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>10500</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>52433</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.05</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2007-11-16</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F3"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>4500</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2017-11-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>155350</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On November 16, 2007, the Reporting Person was granted 10,500 Restricted Stock Units as compensation for serving as an
 independent director of the Issuer. Each Restricted Stock Unit consists of a right to the issuance of one share of Common
 Stock. The Restricted Stock Units are subject to a one-year vesting period.</footnote>
        <footnote id="F2">Represents the amount of securities beneficially owned by the Reporting Person as of the date hereof.</footnote>
        <footnote id="F3">On November 16, 2007, the Reporting Person was granted a stock option to purchase 4,500 shares of Common Stock at an exercise
 price of $3.05 per share as compensation for serving as an independent director of the Issuer. These stock options are
 subject to a one-year vesting period, with an initial monthly vesting date of December 16, 2007.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ ROBERT CANARICK</signatureName>
        <signatureDate>2008-08-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----